Search Results - "Veronica, Sendersky"

2315 12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, multicenter non-interventional EXPERIENCE study by Villanueva, Vicente, D’Souza, Wendyl J, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Adam, Strzelczyk, Szaflarski, Jerzy, Kristen, Ricchetti-Masterson, Cédric, Laloyaux, Veronica, Sendersky, Sophia, Zhou, Florin, Floricel, Daniels, Tony, Bernhard, Steinhoff J

“…ObjectivesTo evaluate effectiveness and tolerability of brivaracetam (BRV) in routine clinical practice in a large, multicenter, international patient…”
Get full text

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients by Curtis, Lesley H, Østbye, Truls, Sendersky, Veronica, Hutchison, Steve, Allen LaPointe, Nancy M, Al-Khatib, Sana M, Usdin Yasuda, Sally, Dans, Peter E, Wright, Alan, Califf, Robert M, Woosley, Raymond L, Schulman, Kevin A

“…Many drugs prolong the QT interval and increase the risk of torsade de pointes. Concurrent use of two or more of these drugs can further increase the risk, but…”
Get more information

An Economic Evaluation of Short-Acting Opioids for Treatment of Breakthrough Pain in Patients with Cancer by Vissers, Debby C.J., MSc, Lenre, Malin, MSc, Tolley, Keith, MPhil, Jakobsson, Jan, MD, PhD, Sendersky, Veronica, PharmD, Jansen, Jeroen P., PhD

“…Abstract Objective Breakthrough cancer pain (BTCP) represents a considerable economic burden. A decision-analysis model was developed to evaluate the…”
Get full text

Inappropriate prescribing for elderly Americans in a large outpatient population by Curtis, Lesley H, Østbye, Truls, Sendersky, Veronica, Hutchison, Steve, Dans, Peter E, Wright, Alan, Woosley, Raymond L, Schulman, Kevin A

“…We sought to determine the extent of potentially inappropriate outpatient prescribing for elderly patients, as defined by the Beers revised list of drugs to be…”
Get more information

Toward estimating the impact of changes in immigrants' insurance eligibility on hospital expenditures for uncompensated care by Castel, Liana D, Timbie, Justin W, Sendersky, Veronica, Curtis, Lesley H, Feather, Keith A, Schulman, Kevin A

“…The Personal Responsibility and Work Opportunity Reconciliation Act (PRWORA) of 1996 gave states the option to withdraw Medicaid coverage of nonemergency care…”
Get full text

12-month Effectiveness and Tolerability of Brivaracetam in Patients with Epilepsy and Cognitive or Psychiatric Comorbidities: Subgroup Data from the International EXPERIENCE Pooled Analysis (P8-1.009) by Villanueva, Vicente, D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Insuga, Victor Soto, Strzelczyk, Adam, Szaflarski, Jerzy P., Besson, Herve, Bourikas, Dimitrios, Daniels, Tony, Floricel, Florin, Friesen, David, Laloyaux, Cedric, Sendersky, Veronica, Steinhoff, Bernhard J.

“…Abstract only…”
Get full text

12-Month Effectiveness and Tolerability of Brivaracetam in the Real-World: The International EXPERIENCE Pooled Analysis (P11-1.003) by Villanueva, Vicente, D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Insuga, Victor Soto, Strzelczyk, Adam, Szaflarski, Jerzy P., Besson, Herve, Daniels, Tony, Floricel, Florin, Laloyaux, Cedric, Sendersky, Veronica, Zhou, Sophia, Steinhoff, Bernhard J.

“…Abstract only…”
Get full text

12-month effectiveness and tolerability of brivaracetam in the real-world: interim analysis of the international, non-interventional EXPERIENCE study (P13-8.002) by Villanueva, Vicente, D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Strzelczyk, Adam, Szaflarski, Jerzy, Ricchetti-Masterson, Kristen, Laloyaux, Cedric, Sendersky, Veronica, Zhou, Sophia, Floricel, Florin, Daniels, Tony, Steinhoff, Bernhard J.

“…Abstract only…”
Get full text

Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records by Villanueva, Vicente, Laloyaux, Cédric, D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Insuga, Victor Soto, Strzelczyk, Adam, Szaflarski, Jerzy P., Chinn, Chris, Daniels, Tony, Floricel, Florin, Friesen, David, Sendersky, Veronica, Besson, Hervé, Steinhoff, Bernhard J.

“…Background and Objective Real-world evidence studies of brivaracetam (BRV) have been restricted in scope, location, and patient numbers. The objective of this…”
Get full text

2576 12-Month effectiveness and tolerability of brivaracetam in patients with epilepsy switching from levetiracetam Vs Other antiseizure medications in the real-world by D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Insuga, Victor Soto, Strzelczyk, Adam, Steinhoff, Bernhard J, Szaflarski, Jerzy P, Besson, Herve, Bourikas, Dimitrios, Daniels, Tony, Floricel, Florin, Friesen, David, Laloyaux, Cedric, Moody, Anita, Sendersky, Veronica, Villanueva, Vicente

“…ObjectivesAssess effectiveness and tolerability of brivaracetam (BRV) in patients switching from levetiracetam (LEV) and from other antiseizure medications…”
Get full text

2628 12-Month effectiveness and tolerability of brivaracetam in the real-world in the international EXPERIENCE pooled analysis: final results and Australian subgroup by D’Souza, Wendyl, Faught, Edward, Klein, Pavel, Reuber, Markus, Rosenow, Felix, Salas-Puig, Javier, Insuga, Victor Soto, Strzelczyk, Adam, Steinhoff, Bernhard J, Szaflarski, Jerzy P, Besson, Herve, Bourikas, Dimitrios, Daniels, Tony, Floricel, Florin, Friesen, David, Laloyaux, Cedric, Sendersky, Veronica, Welton, Jeremy, Villanueva, Vicente

“…ObjectivesAssess effectiveness/tolerability of brivaracetam (BRV) in routine practice in a large international population (Spain/Germany/Australia/United…”
Get full text